You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 4, 2025

Drugs in ATC Class A09A


✉ Email this page to a colleague

« Back to Dashboard


Subclasses in ATC: A09A - DIGESTIVES, INCL. ENZYMES

A09A Market Analysis and Financial Projection

The global market for ATC Class A09A (Digestives, including enzymes) is experiencing robust growth driven by rising digestive health awareness and technological advancements, while its patent landscape reflects innovation in enzyme formulations and production methods.


Market Dynamics

Growth Drivers

  • Demand Surge: The market size reached $1.48 billion in 2024 (Grandview Research) [1] and is projected to grow at a 6.2% CAGR through 2030, with alternative estimates suggesting even faster growth (e.g., 9.4% CAGR from $644 million in 2023 to $1.4 billion by 2029) [3][7].
  • Key Drivers:
    • Rising prevalence of digestive disorders (lactose intolerance, pancreatic insufficiency) [1][14].
    • Aging populations and increased healthcare spending [1][13].
    • Expansion of plant-based and microbial enzyme products [1][3].

Segmentation

  • Animal-Based Enzymes: Dominant in 2024 for treating severe conditions like pancreatic cancer [1].
  • Plant-Based Innovations: Gaining traction due to consumer preference for natural solutions (e.g., DSM-Firmenich’s Maxilact®Next for lactose-free dairy) [3][13].

Regional Trends

  • Asia-Pacific: Fastest-growing region (CAGR 9.9%) due to urbanization, rising disposable incomes, and expanding product availability in China and India [1][14].
  • North America: Largest market share, driven by advanced R&D and high consumer awareness [14].
  • Europe: The UK leads with strong demand for gut health products [1].

Patent Landscape

Classification Overview

  • ATC Class A09A includes:
    • A09AA: Enzyme preparations (e.g., multienzymes like lipase-protease blends) [2][4].
    • A09AB: Acid preparations (e.g., citric acid, glutamic acid hydrochloride) [4][6][8].
    • A09AC: Enzyme-acid combinations [4].

Innovation Focus

  • Production Methods: Patents like EP3625334A1 cover recombinant enzyme manufacturing, emphasizing purity and scalability for food/pharmaceutical use [11].
  • Automated Landscaping: Advances in AI-driven patent analysis (e.g., neural networks) improve efficiency in identifying niche technologies, critical for competitive strategies [10].
  • Natural Sources: Over 7,000 patents reference medicinal plants, aligning with trends in plant-based enzyme supplements [9].

Regulatory and Competitive Pressures

  • High R&D costs and regulatory hurdles drive consolidation, with leaders like Abbott and Amway investing in novel formulations [14].

Competitive Landscape

  • Top Players: Enzymedica, Advanced Enzyme Technologies, and Metagenics lead through partnerships and product diversification [1][14].
  • Strategies:
    • Expansion into personalized nutrition (e.g., enzyme-probiotic blends) [3].
    • Focus on stability and bioavailability enhancements [13].

Key Takeaways

  1. The A09A market is buoyed by aging populations and dietary shifts, with plant-based enzymes poised to challenge animal-derived dominance.
  2. Patent activity highlights innovation in production efficiency and natural sourcing, supported by AI-driven landscape tools.
  3. Regional growth disparities underscore opportunities in emerging markets like Asia-Pacific.

Highlight: "Novel formulations associated with plant-based enzymes are considered noteworthy developments for the future" [1].

Example Patent Flow:  
1. Research ➔ 2. Patent Filing (e.g., enzyme purification methods) ➔ 3. Regulatory Approval ➔ 4. Commercialization

References

  1. https://www.grandviewresearch.com/industry-analysis/digestive-enzyme-supplements-market
  2. https://atcddd.fhi.no/atc_ddd_index/?code=A09A&showdescription=yes
  3. https://www.gminsights.com/industry-analysis/digestive-enzymes-market
  4. https://en.wikipedia.org/wiki/ATC_code_A09
  5. https://www.skyquestt.com/report/digestive-enzyme-supplement-market
  6. https://pubchem.ncbi.nlm.nih.gov/compound/Citric-Acid
  7. https://www.databridgemarketresearch.com/reports/global-digestive-enzymes-market
  8. https://go.drugbank.com/drugs/DB00142
  9. https://www.phytojournal.com/archives/2017/vol6issue6/PartAB/6-4-459-612.pdf
  10. https://arxiv.org/abs/2407.08001
  11. https://patents.google.com/patent/EP3625334A1/en
  12. https://www.drugpatentwatch.com/p/atc-class/A
  13. https://www.futuremarketinsights.com/reports/digestive-enzyme-supplements-market
  14. https://www.alliedmarketresearch.com/digestive-enzymes-market-A08198

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.